such as those for Avandia (rosiglitazone; GlaxoSmithKline) last year. “It does appear that the agency is changing how it assesses benefits and risks when it approves new products. It is ...

It is generally well appreciated that the pharmaceutical industry has entered a period of revenue underperformance. However, the severity of this underperformance, even when measured against ...

Showcase your company news with guaranteed exposure both in print and online Join us for an illuminating exploration of New Mexico's energy landscape at this year… Future of Bay Area Biotech ...

As the U.S. dairy industry confronts an outbreak of bird flu, the egg industry serves as an example of how to slow the spread of the disease but also how difficult it can be to completely ...

Are we entering a new era of supply shortages? It certainly seems like it. In addition to new reports that orange juice is in short supply, drugs – the stu… ...